Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. The company is headquartered in Alameda, California and currently employs 4,500 full-time employees. The company went IPO on 2015-09-18. The firm's broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe. The company focuses on developing, manufacturing and marketing novel products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. Some of the conditions it focuses on are Pulmonary Embolism, Deep Vein Thrombosis, Acute Limb Ischemia, Ischemic Stroke, Acute Coronary Syndrome, and Clot associated with Arteriovenous Graft or Fistula. The firm sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
Follow-Up Questions
Quel est le ratio P/E de Penumbra Inc (PEN) ?
Le ratio P/E de Penumbra Inc est de 712.3214
Qui est le CEO de Penumbra Inc ?
Mr. Adam Elsesser est le Chairman of the Board de Penumbra Inc, il a rejoint l'entreprise depuis 2004.
Quelle est la performance du prix de l'action PEN ?
Le prix actuel de PEN est de $235.08, il a increased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Penumbra Inc ?
Penumbra Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Penumbra Inc ?
La capitalisation boursière actuelle de Penumbra Inc est de $9.1B
Est-ce que Penumbra Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 20 analystes ont établi des notations d'analystes pour Penumbra Inc, y compris 8 achat fort, 10 achat, 5 maintien, 0 vente et 8 vente forte
